Jun 24, 2025 11:00
IBIO - iBio, Inc. Common Stock
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
0.8 0.03 (3.85%) | --- | --- | 0.0 (0.12%) | 0.01 (1.1%) | 0.04 (5.48%) | -0.02 (-2.18%) | -0.02 (-2.18%) |
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- -1.75
- Diluted EPS:
- -1.75
- Basic P/E:
- -0.4749
- Diluted P/E:
- -0.4749
- RSI(14) 1m:
- 10.96
- VWAP:
- 0.83
- RVol:
- 1.4689
Events
Period | Kind | Movement | Occurred At |
---|---|---|---|
1m | Price increase 1m | 0.85 +0.01 (+1.16%) | Oct 15 15:59 |
1m | Price decrease 1m | 0.81 -0.01 (-1.1%) | Oct 15 13:23 |
1m | Price decrease 1m | 0.81 -0.01 (-1.23%) | Oct 15 10:28 |
1m | Price increase 1m | 0.84 +0.01 (+1.19%) | Oct 15 09:59 |
Related News
Jan 02, 2025 12:00
Oct 14, 2024 14:58
Sep 03, 2024 11:00
Jun 03, 2024 11:00
May 13, 2024 20:05
Mar 28, 2024 10:52
Mar 27, 2024 11:00
Mar 26, 2024 23:35
Feb 26, 2024 12:45